Neoadjuvant Tyrosine Kinase Inhibitors (TKIs) Efficacy in EGFR Positive Stage III Nonsmall Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
07:30am - 03:35pm EST - April 6, 2024
07:30am - 03:35pm EST - April 6, 2024
Abstract: JNCCN23-0778 https://jnccn.org/view/journal...
Author(s):
- John Kelvin Lalusis, MD, Medica Oncology Fellow, Saint Luke's Medical Center Philippines
Tags: Clinical Oncology
| Display Label | Action |
|---|---|
| AC24P134 - Neoadjuvant Tyrosine Kinase Inhibitors (TKIs) Efficacy in EGFR Positive Stage III Nonsmall Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis | Download MP3 |